Hypertrophic and polyposis synonasal mucosa (SM) changes in children with atopic bronchial asthma (BA) and allergic rhinitis (AR) Source: Virtual Congress 2021 – New insight into the immunology of allergies, asthma and COPD: from mouse to man Year: 2021
A comparison of fluticasone propionate (FP) and mometasone furoate (MF) nasal spray in the treatment of nasal polyposis associated with asthma Source: Eur Respir J 2006; 28: Suppl. 50, 314s Year: 2006
Evaluation of fluticasone (flixonase) nasal spray versus beclomethasone (beconase) nasal spray in the treatment of allergic rhinitis Source: Eur Respir J 2004; 24: Suppl. 48, 124s Year: 2004
Comparison of fluticasone propionate + salmeterol (FP+S) and montelukast (MK) on bronchial reactivity (BR), pulmonary function (PF) and clinical outcome in children with mild asthma Source: Annual Congress 2009 - Drug treatment of childhood asthma: the controversies and the issues Year: 2009
Fluticasone furoate, a novel inhaled corticosteroid (ICS), provides sustained protection against amp airway hyperresponsiveness (AHR) in mild asthma Source: Annual Congress 2009 - New drugs for airways disease Year: 2009
Dupilumab improves all ACQ-5 individual items in patients with chronic rhinosinusitis with nasal polyposis (CRSwNP) and asthma: results from a phase 2a trial Source: International Congress 2017 – Asthma and allergy: from the bench to the bedside Year: 2017
The contents of α1-acid glycoprotein (α1-AGP) and metabolites of nitric oxide (NO) in nasal lavage fluid (NLF) of patients with bronchial asthma (BA) and allergic rhinitis (AR) and house dust mites (HDM) exposure Source: Eur Respir J 2001; 18: Suppl. 33, 43s Year: 2001
The content of metabolites of nitric oxide (NO) in nasal lavage fluid (NLF) and expired air condensates (EAC) of adolescents with bronchial asthma (BA) and allergic rhinitis (AR) Source: Eur Respir J 2001; 18: Suppl. 33, 39s Year: 2001
E-cadherin (CDH-1 ) polymorphisms associate with airway remodeling, inflammation and FEV1 decline in asthma patients using inhaled corticosteroids (ICS) Source: Annual Congress 2010 - The impact of genes and environment on obstructive airway diseases Year: 2010
Treatment of inflammatory diseases of the nose Source: ISSN=1025-448x, ISBN=1-904097-19-21, page=165 Year: 2001
A combined bronchial, oral, and nasal challenge for aspirin-induced asthma Source: Eur Respir J 2004; 24: Suppl. 48, 444s Year: 2004
Comparative effects of triamcinolone acetonide aqueous nasal spray (TAA) versus cetirizine (CZ) in seasonal allergic rhinitis (SAR) Source: Eur Respir J 2001; 18: Suppl. 33, 270s Year: 2001
Effect of switching from high-dose inhaled corticosteroid (ICS) to low-dose ICS plus an inhaled long-acting β2 -agonist on asthma control, airway inflammation and remodeling, and gene expression in airway epithelial cells Source: Eur Respir J 2003; 22: Suppl. 45, 35s Year: 2003
In vivo dose response relation of inhaled fluticasone propionate (FP), adults with bronchial asthma Source: Eur Respir J 2004; 24: Suppl. 48, 132s Year: 2004
Treatment with inhaled steroids in patients with symptoms suggestive of asthma but with normal lung function Source: Eur Respir J 2008; 32: 989-996 Year: 2008
A comparison of oral loratadine and fluticasone propionate aqueous nasal spray plus oral loratadine in the treatment of atopic cough associated with seasonal allergic rhinitis (SAR) Source: Eur Respir J 2005; 26: Suppl. 49, 136s Year: 2005
New morphologic conception of allergic rhinitis (AR) and bronchial asthma (BA) Source: Annual Congress 2009 - Novel mechanisms in the pathogenesis of asthma Year: 2009
A comparison of clinical characteristics between cough variant asthma (CVA) and bronchial asthma (BA) in adult patients Source: Annual Congress 2010 - Asthma aspect of diagnosis and criteria for follow-up Year: 2010
Salmeterol/fluticasone propionate combination (SFC) improves airways hyperresponsiveness (AHR), lung function and symptoms in adult patients with mild asthma Source: Eur Respir J 2004; 24: Suppl. 48, 262s Year: 2004
Effect of the leukotriene-receptor antagonists and interval hypoxic trainings (IHT) at children with asthma (BA) and allergic rhinitis (AR) Source: Annual Congress 2008 - Exercise-induced asthma, acute severe asthma and allergic rhinitis in children Year: 2008